{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:23:26Z","timestamp":1791638606750,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Research Foundation","doi-asserted-by":"crossref","award":["CRRPVVK0013"],"award-info":[{"award-number":["CRRPVVK0013"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 110-2314-B-182A-154-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-182A-154-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11060-023-04517-x","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T05:02:19Z","timestamp":1701925339000},"page":"535-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study"],"prefix":"10.1007","volume":"165","author":[{"given":"Ko-Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ching","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Kan","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Chieh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hong","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"4517_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"4517_CR2","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret E et al (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32:4655\u20134662","journal-title":"Anticancer Res"},{"key":"4517_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"key":"4517_CR4","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1200\/JCO.2015.60.9503","volume":"33","author":"X Lin","year":"2015","unstructured":"Lin X, DeAngelis LM (2015) Treatment of brain metastases. J Clin Oncol 33:3475\u20133484. https:\/\/doi.org\/10.1200\/JCO.2015.60.9503","journal-title":"J Clin Oncol"},{"key":"4517_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","volume":"20","author":"CD Arvanitis","year":"2020","unstructured":"Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20:26\u201341. https:\/\/doi.org\/10.1038\/s41568-019-0205-x","journal-title":"Nat Rev Cancer"},{"key":"4517_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01054-1","author":"MJ van den Bent","year":"2023","unstructured":"van den Bent MJ et al (2023) Primary brain tumours in adults. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(23)01054-1","journal-title":"Lancet"},{"key":"4517_CR7","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","volume":"5","author":"MD Walker","year":"1979","unstructured":"Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725\u20131731. https:\/\/doi.org\/10.1016\/0360-3016(79)90553-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.prro.2016.03.007","volume":"6","author":"AR Cabrera","year":"2016","unstructured":"Cabrera AR et al (2016) Radiation therapy for glioblastoma: executive summary of an american society for radiation oncology evidence-based clinical practice guideline. Pract Radiat Oncol 6:217\u2013225. https:\/\/doi.org\/10.1016\/j.prro.2016.03.007","journal-title":"Pract Radiat Oncol"},{"key":"4517_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V et al (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 12:265\u2013282. https:\/\/doi.org\/10.1016\/j.prro.2022.02.003","journal-title":"Pract Radiat Oncol"},{"key":"4517_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13014-021-01767-9","volume":"16","author":"G Minniti","year":"2021","unstructured":"Minniti G, Niyazi M, Alongi F, Navarria P, Belka C (2021) Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol 16:36. https:\/\/doi.org\/10.1186\/s13014-021-01767-9","journal-title":"Radiat Oncol"},{"key":"4517_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijrobp.2017.08.038","volume":"100","author":"W Shi","year":"2018","unstructured":"Shi W et al (2018) Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: a secondary analysis of NRG oncology\/radiation therapy oncology group trial 0525. Int J Radiat Oncol Biol Phys 100:38\u201344. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.22.00164","volume":"41","author":"CI Tsien","year":"2023","unstructured":"Tsien CI et al (2023) NRG Oncology\/RTOG1205: a randomized phase II trial of concurrent bevacizumab and reirradiation versus bevacizumab alone as treatment for recurrent glioblastoma. J Clin Oncol 41:1285\u20131295. https:\/\/doi.org\/10.1200\/JCO.22.00164","journal-title":"J Clin Oncol"},{"key":"4517_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/156800909788166637","volume":"9","author":"V Amberger-Murphy","year":"2009","unstructured":"Amberger-Murphy V (2009) Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9:381\u2013390. https:\/\/doi.org\/10.2174\/156800909788166637","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"4517_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/cancers13051102","volume":"13","author":"AE Kabakov","year":"2021","unstructured":"Kabakov AE, Yakimova AO (2021) Hypoxia-induced cancer cell responses driving radioresistance of hypoxic tumors: approaches to targeting and radiosensitizing. Cancers (Basel) 13(5):1102. https:\/\/doi.org\/10.3390\/cancers13051102","journal-title":"Cancers (Basel)"},{"key":"4517_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109\u2013122. https:\/\/doi.org\/10.1016\/0360-3016(91)90171-y","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR16","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.ijrobp.2009.02.091","volume":"76","author":"YR Lawrence","year":"2010","unstructured":"Lawrence YR et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20\u201327. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.091","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fonc.2012.00073","volume":"2","author":"D Greene-Schloesser","year":"2012","unstructured":"Greene-Schloesser D et al (2012) Radiation-induced brain injury: a review. Front Oncol 2:73. https:\/\/doi.org\/10.3389\/fonc.2012.00073","journal-title":"Front Oncol"},{"key":"4517_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","volume":"169","author":"M Aryal","year":"2013","unstructured":"Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N (2013) Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 169:103\u2013111. https:\/\/doi.org\/10.1016\/j.jconrel.2013.04.007","journal-title":"J Control Release"},{"key":"4517_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jconrel.2014.05.033","volume":"187","author":"Z Kovacs","year":"2014","unstructured":"Kovacs Z et al (2014) Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release 187:74\u201382. https:\/\/doi.org\/10.1016\/j.jconrel.2014.05.033","journal-title":"J Control Release"},{"key":"4517_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","volume":"250","author":"J Park","year":"2017","unstructured":"Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N (2017) Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J Control Release 250:77\u201385. https:\/\/doi.org\/10.1016\/j.jconrel.2016.10.011","journal-title":"J Control Release"},{"key":"4517_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ijc.22732","volume":"121","author":"LH Treat","year":"2007","unstructured":"Treat LH et al (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901\u2013907. https:\/\/doi.org\/10.1002\/ijc.22732","journal-title":"Int J Cancer"},{"key":"4517_CR22","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.ultrasmedbio.2012.04.015","volume":"38","author":"LH Treat","year":"2012","unstructured":"Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38:1716\u20131725. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2012.04.015","journal-title":"Ultrasound Med Biol"},{"key":"4517_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058995","volume":"8","author":"KC Wei","year":"2013","unstructured":"Wei KC et al (2013) Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS ONE 8:e58995. https:\/\/doi.org\/10.1371\/journal.pone.0058995","journal-title":"PLoS ONE"},{"key":"4517_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd0772","author":"KT Chen","year":"2021","unstructured":"Chen KT et al (2021) Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abd0772","journal-title":"Sci Adv"},{"key":"4517_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fphar.2019.00086","volume":"10","author":"KT Chen","year":"2019","unstructured":"Chen KT, Wei KC, Liu HL (2019) Theranostic strategy of focused ultrasound induced blood-brain barrier opening for CNS disease treatment. Front Pharmacol 10:86. https:\/\/doi.org\/10.3389\/fphar.2019.00086","journal-title":"Front Pharmacol"},{"key":"4517_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","volume":"17","author":"Y Meng","year":"2021","unstructured":"Meng Y, Hynynen K, Lipsman N (2021) Applications of focused ultrasound in the brain: from thermoablation to drug delivery. Nat Rev Neurol 17:7\u201322. https:\/\/doi.org\/10.1038\/s41582-020-00418-z","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"4517_CR27","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics13071084","volume":"13","author":"KT Chen","year":"2021","unstructured":"Chen KT, Wei KC, Liu HL (2021) Focused ultrasound combined with microbubbles in central nervous system applications. Pharmaceutics 13(7):1084. https:\/\/doi.org\/10.3390\/pharmaceutics13071084","journal-title":"Pharmaceutics"},{"key":"4517_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","volume":"134","author":"SH Park","year":"2020","unstructured":"Park SH et al (2020) Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg 134:475\u2013483. https:\/\/doi.org\/10.3171\/2019.10.JNS192206","journal-title":"J Neurosurg"},{"key":"4517_CR29","doi-asserted-by":"publisher","first-page":"343re342","DOI":"10.1126\/scitranslmed.aaf6086","volume":"8","author":"A Carpentier","year":"2016","unstructured":"Carpentier A et al (2016) Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci Transl Med 8:343re342. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6086","journal-title":"Sci Transl Med"},{"key":"4517_CR30","doi-asserted-by":"publisher","first-page":"eabj4011","DOI":"10.1126\/scitranslmed.abj4011","volume":"13","author":"Y Meng","year":"2021","unstructured":"Meng Y et al (2021) MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Sci Transl Med 13:eabj4011. https:\/\/doi.org\/10.1126\/scitranslmed.abj4011","journal-title":"Sci Transl Med"},{"key":"4517_CR31","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1109\/EMBC.2013.6609710","volume":"1152\u20131155","author":"WH Lin","year":"2013","unstructured":"Lin WH, Fan CH, Ting CY, Liu HL, Yeh CK (2013) Dynamic perfusion assessment by contrast-enhanced ultrasound in blood-brain barrier disruption. Annu Int Conf IEEE Eng Med Biol Soc 1152\u20131155:2013. https:\/\/doi.org\/10.1109\/EMBC.2013.6609710","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"4517_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1298\/jjpta.Vol17_001","volume":"17","author":"K Morishita","year":"2014","unstructured":"Morishita K et al (2014) Effects of therapeutic ultrasound on intramuscular blood circulation and oxygen dynamics. J Jpn Phys Ther Assoc 17:1\u20137. https:\/\/doi.org\/10.1298\/jjpta.Vol17_001","journal-title":"J Jpn Phys Ther Assoc"},{"key":"4517_CR33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01059","author":"PY Wen","year":"2023","unstructured":"Wen PY et al (2023) RANO 2.0: update to the response assessment in neuro-oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.23.01059","journal-title":"J Clin Oncol"},{"key":"4517_CR34","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY et al (2020) Glioblastoma in adults: a society for neuro-oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073\u20131113. https:\/\/doi.org\/10.1093\/neuonc\/noaa106","journal-title":"Neuro Oncol"},{"key":"4517_CR35","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM et al (2010) Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76:S3\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR36","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10\u2013S19. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.07.1754","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13014-023-02215-6","volume":"18","author":"KE Blethen","year":"2023","unstructured":"Blethen KE et al (2023) Effects of whole-brain radiation therapy on the blood-brain barrier in immunocompetent and immunocompromised mouse models. Radiat Oncol 18:22. https:\/\/doi.org\/10.1186\/s13014-023-02215-6","journal-title":"Radiat Oncol"},{"key":"4517_CR38","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/0360-3016(90)90364-p","volume":"19","author":"DX Qin","year":"1990","unstructured":"Qin DX, Zheng R, Tang J, Li JX, Hu YH (1990) Influence of radiation on the blood-brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys 19:1507\u20131510. https:\/\/doi.org\/10.1016\/0360-3016(90)90364-p","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4517_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/a:1006337912345","volume":"44","author":"JC Adair","year":"1999","unstructured":"Adair JC, Baldwin N, Kornfeld M, Rosenberg GA (1999) Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase. J Neurooncol 44:283\u2013289. https:\/\/doi.org\/10.1023\/a:1006337912345","journal-title":"J Neurooncol"},{"key":"4517_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.brainres.2011.11.022","volume":"1433","author":"W Fauquette","year":"2012","unstructured":"Fauquette W, Amourette C, Dehouck MP, Diserbo M (2012) Radiation-induced blood-brain barrier damages: an in vitro study. Brain Res 1433:114\u2013126. https:\/\/doi.org\/10.1016\/j.brainres.2011.11.022","journal-title":"Brain Res"},{"key":"4517_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109633","volume":"183","author":"PJ Li","year":"2023","unstructured":"Li PJ et al (2023) Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma. Radiother Oncol 183:109633. https:\/\/doi.org\/10.1016\/j.radonc.2023.109633","journal-title":"Radiother Oncol"},{"key":"4517_CR42","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.ultrasmedbio.2020.04.013","volume":"46","author":"PJ White","year":"2020","unstructured":"White PJ, Zhang YZ, Power C, Vykhodtseva N, McDannold N (2020) Observed effects of whole-brain radiation therapy on focused ultrasound blood-brain barrier disruption. Ultrasound Med Biol 46:1998\u20132006. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2020.04.013","journal-title":"Ultrasound Med Biol"},{"key":"4517_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13014-015-0562-x","volume":"10","author":"PF Tsai","year":"2015","unstructured":"Tsai PF et al (2015) Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Radiat Oncol 10:253. https:\/\/doi.org\/10.1186\/s13014-015-0562-x","journal-title":"Radiat Oncol"},{"key":"4517_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/neuonc\/noaa193","volume":"23","author":"WC Yang","year":"2021","unstructured":"Yang WC et al (2021) Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial. Neuro Oncol 23:478\u2013486. https:\/\/doi.org\/10.1093\/neuonc\/noaa193","journal-title":"Neuro Oncol"}],"updated-by":[{"DOI":"10.1007\/s11060-024-04671-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04517-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T03:04:43Z","timestamp":1712804683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04517-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["4517"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04517-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11060-024-04671-w","URL":"https:\/\/doi.org\/10.1007\/s11060-024-04671-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}